World Health Organization Hails Pharmacia's Generic HIV/AIDS Treatment Accord
January 28, 2003
On Monday in Geneva, the World Health Organization hailed the news that Pharmacia will license a Dutch group to provide developing countries with a generic treatment for HIV/AIDS. The U.S. drug maker on Friday confirmed a partnership with the Dutch foundation International Dispensary Association to grant non-exclusive licenses for the HIV/AIDS drug delavirdine to generic pharmaceutical companies. "WHO welcomes new initiatives by some innovator companies to license their patents for certain HIV/AIDS medicines to generic companies," the UN agency said in a statement. "Such voluntary licensing can increase competition, reduce prices, and thereby give poorer people greater access to medicines."Adapted from:
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.